Dr. Kiran Kumar Devulapally, MD

Dr. Devulapally practices at OhioHealth Grant Medical Center in Columbus, Ohio, part of OhioHealth.

Dr. Devulapally's NPI, 1659326445, was assigned on May 23, 2006. Dr. Devulapally graduated from Gandhi Medical College in 1995. Dr. Devulapally holds Ohio license 35079965.

Dr. Devulapally's primary practice is OhioHealth Grant Medical Center, at 111 South Grant Avenue, Columbus, OH 43215 in Franklin County. The practice phone is (614) 566-9164.

Dr. Devulapally's primary practice is OhioHealth Grant Medical Center in Columbus, Ohio, part of OhioHealth. Dr. Devulapally is also affiliated with OhioHealth Riverside Methodist Hospital. The medical group on file is OhioHealth Physician Group. Dmand AI also links Dr. Devulapally to 3 more hospitals and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devulapally practices, 6 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Devulapally's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Devulapally is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Devulapally's licenses on file in 2 states: Ohio and Pennsylvania.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, pulmonary heart disease, sleep apnea and tobacco use among the conditions Dr. Devulapally treats.

CMS data shows 835 Medicare services from Dr. Devulapally across 11 procedure codes in 2024, for 296 Medicare patients. Medicare paid $81,001 for them.

CMS counts 296 Medicare patients who saw Dr. Devulapally in 2024. The largest group is 65 to 74, with 127 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devulapally's median patient age at 68, with 46% women.

In 2024, Dr. Devulapally wrote 1,299 Medicare Part D claims for 181 patients. 51% of them were for generic drugs. CMS names the drug for 1,165 of them, across 24 drugs with 11 or more claims each, at $278,395 in total drug cost. In 2023, CMS named 1,137 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Devulapally for performance year 2024, reported as part of a group. Dr. Devulapally accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devulapally as offering telehealth.

Dmand AI links 3 papers to Dr. Devulapally. Dr. Devulapally's most frequent co-author is Aaron Scott Bruns, MD.

Dmand AI links Dr. Devulapally to 3 clinical trials, 2 of them phase 2 studies. Conditions studied include COVID-19, Pneumonia, Viral and Hypoventilation. CytoDyn, Inc. sponsors the most, 2.

CMS Open Payments shows 31 general payments to Dr. Devulapally from 10 drug and device companies from 2016 to 2025. Education make up the largest share, 47% of the total. Intuitive Surgical, Inc. paid the most, $5,511.

Dr. Devulapally graduated from Gandhi Medical College in 1995.

Dr. Devulapally is in network with 18 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.